Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

7.5K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.5K
The Tumor Microenvironment02:17

The Tumor Microenvironment

6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Tumor Progression02:07

Tumor Progression

6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Tumor Immunotherapy01:27

Tumor Immunotherapy

567
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
567
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

9.0K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.0K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

[The problem of determining tumor cell content].

Pathologie (Heidelberg, Germany)·2026
Same author

Enhancing the performance and interpretability of epigenetic clocks.

Nucleic acids research·2026
Same author

Literature-informed gene extraction and ranking for multimodal data fusion.

Briefings in bioinformatics·2026
Same author

A Dataset of Benchmark Boolean Models for Gene Regulatory Networks.

Scientific data·2026
Same author

Evaluation of single-nucleotide variants in bladder cancer using prediction algorithms.

Pathologie (Heidelberg, Germany)·2025
Same author

Identification of ordinal relations and alternative suborders within high-dimensional molecular data.

Frontiers in bioinformatics·2025

相关实验视频

Updated: Jul 23, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.3K

珀 - 分子瘤板的交互式改变注释.

Axel Fürstberger1, Nensi Ikonomi2, Angelika M R Kestler3

  • 1Institute of Medical Systems Biology, Ulm University, Ulm 89081, Germany; Department of Pathology, Ulm University Hospital, Ulm 89081, Germany; Zentrum Personalisierte Medizin, Ulm University Hospital, Ulm 89081, Germany.

Computer methods and programs in biomedicine
|July 13, 2023
PubMed
概括

分子瘤板 (MTB) 现在可以通过AMBAR,一个交互式Web应用程序,简化癌症治疗决策. 安巴尔促进了对患者数据的有效分析和记录,改善了个性化治疗规划.

关键词:
互动应用程序 互动应用程序更多的MTBs是因为MTB.个性化医疗是个性化的医疗.

更多相关视频

A Next-generation Tissue Microarray ngTMA Protocol for Biomarker Studies
09:32

A Next-generation Tissue Microarray ngTMA Protocol for Biomarker Studies

Published on: September 23, 2014

24.1K
Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

6.8K

相关实验视频

Last Updated: Jul 23, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.3K
A Next-generation Tissue Microarray ngTMA Protocol for Biomarker Studies
09:32

A Next-generation Tissue Microarray ngTMA Protocol for Biomarker Studies

Published on: September 23, 2014

24.1K
Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

6.8K

科学领域:

  • 在瘤学瘤学.
  • 生物信息学是一种生物信息学.
  • 医疗信息学 医疗信息学

背景情况:

  • 个性化癌症治疗依赖于分子分析和专家知识.
  • 分子瘤板 (MTBs) 整合了治疗决策的各种专业知识.
  • 目前的MTB数据分析是耗时的,缺乏适当的工具.

研究的目的:

  • 开发一个交互式网络应用程序,AMBAR (分子瘤板的变化注释),以支持MTB的治疗决策.

主要方法:

  • 开发了AMBAR作为一个基于R shiny的交互式Web应用程序.
  • 集成的功能用于定制,交互式过和数据可视化.
  • 启用了对突变的注释和对临床系统的导出.

主要成果:

  • AMBAR提供了一个用户友好的界面来管理和分析患者的分子数据.
  • 该应用程序有助于将专家知识纳入决策过程.
  • 安巴支持有效的记录和出口注释突变用于临床使用.

结论:

  • 安巴尔解决了当前MTB数据管理的局限性,提高了效率和准确性.
  • 该工具通过改进分子数据和专家知识的整合来支持个性化癌症治疗.
  • AMBAR是一个开源的,多克化的应用程序,可在临床环境中更广泛地采用.